Quality of Life (QOL), a construct which has not yet achieved precise definition in the medical literature, nonetheless is a necessary outcome variable requiring measurement in determining comprehensive menopausal status in the clinical context or as part of pivotal regulatory trial research. Current QOL measures are mostly symptom inventories or scores relating to specific life phases or diseases.
Reprinted with permission
COGI Paris
Quality of Life (QOL), a construct which has not yet achieved precise definition in the medical literature, nonetheless is a necessary outcome variable requiring measurement in determining comprehensive menopausal status in the clinical context or as part of pivotal regulatory trial research. Current QOL measures are mostly symptom inventories or scores relating to specific life phases or diseases.
We have reported on the Utian Quality of Life (UQOL) instrument. This is a brief instrument which measures QOL during the perimenopausal years through a 23-item questionnaire which demonstrates four separate intercorrelated domains. The UQOL with its simplicity of administration should be of practical value in clinical practice in evaluating QOL and changes in QOL in different communities and cultures.
Unfortunately, at this time, no such validated tool has been used in clinical studies, although the UQOL is currently being tested in HRT trials.
In the absence of definitive data, only speculation can be made as to whether HRT enhances QOL.
Early preterm birth risk linked to low PlGF levels during pregnancy screening
November 20th 2024New research highlights that low levels of placental growth factor during mid-pregnancy screening can effectively predict early preterm birth, offering a potential tool to enhance maternal and infant health outcomes.
Read More
Improved maternal cardiac arrest management reported from Obstetric Life Support training
November 19th 2024A study found that Obstetric Life Support education significantly improves health care providers' readiness and outcomes in maternal cardiac arrest management, advocating for broader implementation.
Read More
IUD placement within 48 hours nonsuperior vs 2 to 4 weeks after abortion
November 19th 2024A study reveals no significant difference in 6-month intrauterine device use between placements within 48 hours or 2 to 4 weeks after a second-trimester abortion, though earlier placement carries a higher expulsion risk.
Read More